NEU support of 0.089 (tight green dotted line) is still in tact.
Assuming that holds the short term outlook is trade inside the range 0f 0.089 to .115.(red dotted line).
High probability move will see the share price close the gap between 0.094-0.095.
Based on the granting of Orphan Drug Designations + interest in Orphan Drug Co's globally, imminent FDA meeting outcomes, the strong positive anecdotal reports via social media on Fragile X trials (consistent to Retts) and the ridiculousness of the fact nothing has changed fundamentally since a successful Phase II in Retts, I know what I will be doing if any more cap loss selling takes place between now and 30 June
Chart - NEU, page-85
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.63 |
Change
-1.080(6.46%) |
Mkt cap ! $1.997B | |||
| Open | High | Low | Value | Volume |
| $16.61 | $16.65 | $15.54 | $8.354M | 529.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 830 | $15.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.74 | 1484 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |